Before Brain Mapping and Neurofeedback: The Psychiatric Differential That Should Come First

Brain mapping and neurofeedback have found the San Francisco market.

Some patients arrive having already had a QEEG — a quantitative EEG that maps brainwave patterns — and are partway through a neurofeedback protocol. Others are asking whether they should get one before we figure out what is actually happening with their focus, mood, or sleep. A third group has spent significant money on these services and is not better.

My honest position: the technology is not the problem. The sequence is.

In most of these cases, the full psychiatric and medical differential was never done. The patient moved from symptom to brain map to protocol without anyone asking whether they are sleeping, what their ferritin is, whether this pattern started before or after a medication, or whether the brainwave finding is cause or consequence.

That sequence matters.

The Fast Answer

• QEEG brain mapping identifies brainwave patterns. It does not diagnose ADHD, depression, anxiety, or any other psychiatric condition by itself.
• Neurofeedback is a learning-based intervention that trains brainwave regulation. The evidence base varies significantly by target condition and protocol.
• Before starting either, the clinical differential should be complete: ADHD, mood disorders, anxiety, trauma history, sleep apnea, thyroid function, ferritin and iron stores, B12, vitamin D, medication effects, substance use, and medical contributors.
• Untreated sleep apnea, low ferritin, hypothyroidism, and stimulant timing problems can all produce brainwave findings and cognitive symptoms. They need treatment, not brainwave training.
• If the differential was skipped, neurofeedback does not fill that gap.

The right question is not whether brain mapping or neurofeedback is legitimate. It is whether the patient is ready for it — meaning whether the reversible and treatable contributors have been identified and addressed first.

Before you keep searching

If this answer changes what you might do next, pick the next clinical question now.

ADHD or burnout after 40 Use this when focus broke under workload, sleep, hormones, anxiety, or perimenopause pressure.Structured ADHD evaluation See the evaluation path before deciding whether medication is even the right next step.Labs may be part of the story Ferritin, thyroid, B12, vitamin D, sleep, and medication response can change the diagnosis.

Or read how adhd assessment works

What QEEG Brain Mapping Actually Shows

A quantitative EEG records electrical activity across the scalp and compares the patient's brainwave patterns — delta, theta, alpha, beta — to normative databases. Some practitioners use this to guide neurofeedback protocols, identify patterns associated with ADHD-related inattention, anxiety, or mood dysregulation, and explain the patient's presentation back to them.

What it does not do: diagnose anything by DSM criteria. A QEEG finding is a correlate, not a cause. Elevated frontal theta relative power, for example, is often cited as an ADHD marker. But frontal theta also increases with sleep deprivation, fatigue, anxiety, sedating medications, and in normal adults who are bored. The pattern on its own does not distinguish these sources.

The FDA has cleared certain QEEG approaches as adjuncts to clinical evaluation, not as standalone diagnostic tools. The word "adjunct" is doing important work in that sentence.

A finding on a brain map does not tell me whether the patient's cognitive problems come from ADHD, sleep apnea, untreated hypothyroidism, low ferritin with anemia, medication side effects, medication underdosing, post-COVID cognitive changes, mood disorder, trauma, or chronic anxiety. Those questions require a clinical history.

Neurofeedback: What The Evidence Actually Says

Neurofeedback for ADHD has a long research history and a genuinely complicated evidence picture.

There are studies showing benefit in attention, impulsivity, and executive function outcomes. There are also rigorous double-blind trials that find the benefits disappear when sham neurofeedback is used as the control — raising the question of how much of the effect is training-specific versus expectation, attention, and practice-task improvement.

A 2019 Cochrane-adjacent systematic review found that effects on inattention and hyperactivity were larger in trials without blinded assessment and smaller in those with. That asymmetry matters.

For other conditions — PTSD, anxiety, depression, insomnia — the evidence base is thinner and more varied. Some specific protocols show promise. None of them are ready to replace a diagnostic evaluation.

What I tell patients: neurofeedback is not snake oil. It is also not a substitute for knowing what you are treating. A patient who does 40 sessions of neurofeedback for ADHD symptoms that are actually driven by sleep apnea or untreated hypothyroidism has spent money and time without fixing the underlying problem. When they stop, the symptoms return — because they were never treated.

What Needs To Come First

Before any brain mapping or neurofeedback protocol, I want these questions answered.

Sleep is the first stop. Unrefreshing sleep, poor sleep efficiency, or frank sleep apnea can produce cognitive and attentional findings that are indistinguishable from ADHD on both clinical history and QEEG. A patient who is sleeping five hours a night and waking unrested is not a neurofeedback candidate — they are a sleep evaluation candidate. If there is any clinical suspicion for obstructive sleep apnea, a home sleep study comes before anything else.

Labs are the second stop. Ferritin below 50 ng/mL can impair dopamine synthesis and produce restlessness, poor sleep, and cognitive symptoms that respond to iron repletion, not brainwave training. TSH and free T4 rule out thyroid contributions to depression, anxiety, and cognitive slowing. B12 and vitamin D round out the basic metabolic picture that is frequently skipped in optimization-focused evaluations.

Psychiatric history is the third stop. Has there ever been a manic, hypomanic, or mixed episode? Unrecognized bipolar-spectrum disorder changes the treatment picture significantly — not just for medication decisions, but because stimulants, certain supplements, and some neurofeedback protocols can activate a patient who has not been appropriately assessed. PTSD and trauma history shape how brainwave-based interventions are tolerated. Prior psychiatric treatment and response history tells me whether we are working with a clean slate or a treatment-complicated picture.

Medication and substance review is the fourth stop. Stimulant medications, benzodiazepines, sedating antihistamines, gabapentinoids, beta-blockers, and alcohol all change EEG patterns. A brain map done without accounting for the patient's medication list may be measuring drug effects rather than trait-level neurobiology.

The fifth stop is the clinical interview — not the symptom checklist. How long has this been happening? Was there a before? What changed? What improved things temporarily even if the benefit did not last? The answers often tell me more about etiology than any device.

Skim Map

What to rule out before brain mapping and neurofeedback

Sleep apnea and sleep debt Unrefreshing sleep and frank sleep apnea produce cognitive and attentional symptoms that look identical to ADHD. They also produce QEEG findings consistent with inattention. Treating sleep apnea resolves both the symptoms and the brainwave pattern — no neurofeedback required.

Low ferritin and iron stores Ferritin below 50 ng/mL impairs dopamine synthesis and can cause restlessness, poor sleep, and attentional difficulties. This is frequently missed in both psychiatric and optimization evaluations. Iron repletion sometimes resolves what looked like ADHD or mood dysregulation.

Thyroid and metabolic contributors Hypothyroidism and subclinical hypothyroidism produce cognitive slowing, mood changes, and fatigue that neither brain maps nor neurofeedback will fix. TSH and free T4 are cheap and fast. They should be done before any device-based intervention.

Mood disorder and bipolar-spectrum risk Unrecognized bipolar-spectrum disorder changes the treatment picture for everything downstream — medications, stimulants, supplements, and some neurofeedback protocols. It cannot be identified by brain map alone and requires a full psychiatric history including past episodes, family history, and medication response patterns.

Medication and substance effects on EEG Stimulants, benzodiazepines, sedating antihistamines, alcohol, and cannabis all change brainwave patterns. A QEEG done without accounting for the full medication and substance picture may be measuring drug effects rather than the patient's underlying neurobiology.

Trauma, PTSD, and chronic anxiety Trauma and PTSD shape cortical arousal patterns in ways that appear on EEG. They also affect how brainwave-based interventions are tolerated. Knowing this before starting matters, both for protocol selection and for understanding what is actually being treated.

The Question I Ask Patients Who Come In Mid-Protocol

If a patient is already partway through a neurofeedback program and is not improving, I want to know what happened before the program started.

Was a standard clinical psychiatric evaluation done — not a questionnaire, but an actual history? Were labs checked? Was sleep assessed? Was the medication list reviewed?

Often the answer is no, or only partially. The patient was screened with a symptom checklist, had a brain map done, received a report describing their pattern in terms that matched their complaints, and started a protocol. The differential was assumed to be negative rather than actually investigated.

That is the sequence problem. Not that neurofeedback is fraudulent, but that it was inserted before the diagnostic work was complete.

When the differential finally gets done, we frequently find something concrete: ferritin that is 18 ng/mL. Sleep apnea that is moderate by AHI. Subclinical hypothyroidism that the TSH almost caught. A stimulant dose that is either too high or too low depending on how they have been eating. A mood pattern that suggests bipolar-II rather than unipolar depression.

These findings need direct treatment. Sometimes after that treatment, the patient no longer wants neurofeedback because the problem is actually resolving.

If Neurofeedback Is Still On The Table After The Differential

I am not categorically against neurofeedback. For patients who have had a complete differential, have addressed the modifiable contributors, and still have residual attentional or regulatory difficulties, it may be a reasonable adjunct.

What I tell patients in that position: go in with realistic expectations. The evidence supports modest benefits in ADHD-related attention for some patients. The effect size is smaller than pharmaceutical treatment. It requires time and commitment — typically 20 to 40 sessions. And the protocol should be guided by a clinician who understands the full picture, not just the QEEG report.

What I do not want is a patient spending $4,000 on brainwave training while their ferritin sits at 12 ng/mL and their sleep apnea goes untreated. That is not optimization. It is a very expensive way to avoid the differential.

Getting Help In San Francisco

Horizon Peak Health offers diagnostic optimization in San Francisco for patients whose cognitive, mood, and performance picture is being managed without a complete diagnostic foundation — including patients who have been through optimization protocols that did not work.

For the broader context on how diagnostic thinking differs from optimization culture, biohacking ethics and psychiatric limits covers where diagnostic medicine and optimization culture diverge. For patients approaching any new treatment including neurofeedback, before changing psychiatric medication outlines the evaluation sequence that should precede any new intervention.

The evaluation should happen before the protocol.

Request a diagnostic evaluation

---

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Neurofeedback, brain mapping, ADHD, mood disorders, sleep disorders, psychiatric medications, and any medical or mental health treatment require individualized evaluation and supervision by qualified clinicians. Do not start, stop, taper, or change psychiatric medications, stimulants, sleep medications, or supplements without guidance from a qualified clinician. Seek urgent help for suicidal thoughts, self-harm urges, mania, psychosis, severe agitation, chest pain, fainting, severe shortness of breath, or another emergency. In a mental health crisis, call or text 988 or go to the nearest emergency room.

---

References

• U.S. Food and Drug Administration. Prescription Stimulant Medications.
• National Heart, Lung, and Blood Institute. Sleep Deprivation and Deficiency.
• National Heart, Lung, and Blood Institute. Sleep Apnea.
• American Thyroid Association. Thyroid Function Tests.
• Centers for Disease Control and Prevention. Diagnosing ADHD. Updated October 3, 2024.